Talk:Andexanet alfa

This is the talk page for discussing improvements to the Andexanet alfa article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Andexanet alfa.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

The following Wikipedia contributors may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

Recbcd (talk · contribs) This user has contributed to the article. (Promotional SPA Per contribs)
Flow234 (talk · contribs) This user has contributed to the article. This user has been banned and may therefore be reverted on sight. (Indeffed for socking)
Mdruschel (talk · contribs) This user has contributed to the article. (Promotional SPA per contribs)
DrLC MD (talk · contribs) This user has contributed to the article. (Promotional SPA per contribs)

Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent.

Brand versus generic[edit]

This is a brand name "Andexxa"[1]

"Andexanet alfa" is the proposed INN[2]

Doc James (talk · contribs · email) 19:55, 5 November 2018 (UTC)[reply]

Actually, "Andexanet alfa" is no longer an appropriate INN for "Andexxa" in US [3]. It is very likely that INN will be changed in EU too. --Recbcd (talk) 15:58, 13 November 2018 (UTC)[reply]